Revenue Net Income P/E P/S EBIT Dividend Stocks Market capitalization Debt Liabilities Equity AAQS Employees ROE ROA ROCE

Anteris Technologies AAQS 2025

Anteris Technologies AAQS

Ticker

AVR.AX

ISIN

AU0000088841

Revenue Net Income P/E P/S EBIT Dividend Stocks Market capitalization Debt Liabilities Equity AAQS Employees ROE ROA ROCE

Anteris Technologies has a current AAQS of 2.

A high AAQS can be seen as a positive indicator that the company is developing successfully.

Investors can assume that the company is on a good path to generate profits.

On the other hand, it is important to consider the AAQS of the stock Anteris Technologies in comparison to the profits generated and other companies in the same industry. A high AAQS is not an absolute guarantee for a positive future. Only in this way can one get a complete picture of the company's performance.

In order to better assess the company's development, it is important to consider the AAQS in comparison to other companies in the same industry. In general, investors should always consider the AAQS of a company in connection with other fundamentals such as profit, EBIT, cash flow, and others in order to make an informed investment decision.

Anteris Technologies Aktienanalyse

What does Anteris Technologies do?

Anteris Technologies Ltd is a groundbreaking British company specialized in researching, developing, and manufacturing innovative medical instruments and implants. It was founded in 2009 by a group of experienced scientists and entrepreneurs and has since had an impressive track record of success. The company's business model is based on utilizing state-of-the-art technology and collaborating with leading medical experts worldwide. Anteris Technologies aims to develop high-quality instruments and implants that enable fast and effective recovery and improve people's lives. The company offers various divisions covering different medical areas, with a focus on orthopedics, neurosurgery, and cardiology. Its orthopedic division focuses on manufacturing implants for treating bone fractures, injuries, and degenerative diseases, including bone replacement products, joint replacement products, and spinal surgery products. The company strives to develop implants that closely resemble natural body parts and facilitate rapid and effective recovery. Its neurosurgery division concentrates on researching and developing products for treating neurological diseases and injuries to the nervous system, such as spinal cord injuries, brain tumors, and epilepsy, in close collaboration with leading neurology experts. The cardiology division focuses on researching and developing products for treating heart diseases and heart attacks, including stents to maintain normal blood flow in the heart and catheters used for minimally invasive surgical procedures. One of the company's notable products is the Vascular Flow Technologies (VFT) Stent, designed specifically for treating coronary heart disease, which features a unique surface coating that reduces the risk of blood clots and enables faster healing. Anteris Technologies is also working on developing new advanced instruments to simplify surgical procedures and reduce recovery time. Overall, Anteris Technologies Ltd has become one of the leading companies in the medical industry. Its experts are dedicated to pushing the boundaries of modern medical treatment and helping patients heal faster and more effectively. With its innovative products and excellent expertise, the company will continue to play a crucial role in the medical industry and improving people's health. Anteris Technologies ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Frequently Asked Questions about Anteris Technologies stock

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Anteris Technologies

Our stock analysis for Anteris Technologies Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Anteris Technologies Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.